Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Fujimoto

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Psychiatry and Clinical Neurosciences|August 30, 2024
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trialYohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2026
Age and sex-dependent alteration in AMPA receptor density in living human brainMai Hatano, Waki Nakajima, Shohei Tsuchimoto, et al.
Molecular Psychiatry|March 4, 2026
The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depressionWaki Nakajima, Mai Hatano, Yohei Ohtani, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Psychiatry and Clinical Neurosciences|August 30, 2024
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trialYohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2026
Age and sex-dependent alteration in AMPA receptor density in living human brainMai Hatano, Waki Nakajima, Shohei Tsuchimoto, et al.
Molecular Psychiatry|March 4, 2026
The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depressionWaki Nakajima, Mai Hatano, Yohei Ohtani, et al.
Pageof 2